Scientist have found evidences of where the brain records the place and time of real-life memories. In a study published…
Articles by Isaura Santos
The biggest risk factor for Alzheimer’s disease (AD) is aging. After the age of 65 the risk doubles every 5 years, with…
A scientist from the University of Oklahoma is developing a new therapy to address Alzheimer’s disease using “biopharmaceutical proteases” to destroy the toxic plaque…
The Alzheimer’s Association and the Paul G. Allen Family Foundation recently announced the award of three grants to assess…
The summer solstice is the longest day of the year, and it is not just for baseball games and backyard barbecues.
A new drug developed at Lancaster University in the United Kingdom that might help to prevent early stages of Alzheimer’s disease…
Aphios Corporation recently announced that United States Patent 9,034,347 has been granted to the company’s lead compound to treat neurodegenerative diseases…
The existence of specific and reliable biomarkers for Alzheimer’s disease are crucial to identifying individuals to enroll in clinical trials so…
NuevaCare recently announced that it will be presenting MnemeTherapy®, its service to address Alzheimer’s disease, at two upcoming seminars.
CereSpir™ Incorporated, a biotechnology company firm advancing CSP-1103, which is a first-in-class modulator of the innate immune system of the brain…